vs
Side-by-side financial comparison of ATLANTIC AMERICAN CORP (AAME) and BillionToOne, Inc. (BLLN). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $53.8M, roughly 1.6× ATLANTIC AMERICAN CORP). BillionToOne, Inc. runs the higher net margin — 6.8% vs 1.1%, a 5.8% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 20.8%). ATLANTIC AMERICAN CORP produced more free cash flow last quarter ($6.6M vs $6.5M).
The Atlantic Telegraph Company was a company formed on 6 November 1856 to undertake and exploit a commercial telegraph cable across the Atlantic Ocean, the first such telecommunications link.
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
AAME vs BLLN — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.8M | $83.5M |
| Net Profit | $577.0K | $5.7M |
| Gross Margin | — | 69.9% |
| Operating Margin | 1.4% | 11.5% |
| Net Margin | 1.1% | 6.8% |
| Revenue YoY | 20.8% | 117.4% |
| Net Profit YoY | 128.9% | 138.3% |
| EPS (diluted) | $0.02 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $53.8M | $83.5M | ||
| Q2 25 | $55.3M | — | ||
| Q1 25 | $50.1M | — | ||
| Q4 24 | $49.0M | $45.1M | ||
| Q3 24 | $44.5M | $38.4M | ||
| Q2 24 | $47.7M | — | ||
| Q1 24 | $47.0M | — | ||
| Q4 23 | $46.7M | — |
| Q3 25 | $577.0K | $5.7M | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $802.0K | — | ||
| Q4 24 | $412.0K | $-11.5M | ||
| Q3 24 | $-2.0M | $-14.9M | ||
| Q2 24 | $-684.0K | — | ||
| Q1 24 | $-2.0M | — | ||
| Q4 23 | $-2.2M | — |
| Q3 25 | — | 69.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 57.1% | ||
| Q3 24 | — | 52.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 1.4% | 11.5% | ||
| Q2 25 | 7.6% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 1.1% | 17.0% | ||
| Q3 24 | -5.5% | -32.9% | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -5.3% | — | ||
| Q4 23 | -6.6% | — |
| Q3 25 | 1.1% | 6.8% | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 0.8% | -25.5% | ||
| Q3 24 | -4.5% | -38.8% | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | -4.3% | — | ||
| Q4 23 | -4.8% | — |
| Q3 25 | $0.02 | $0.10 | ||
| Q2 25 | $0.15 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.01 | $-1.13 | ||
| Q3 24 | $-0.10 | $-1.47 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.10 | — | ||
| Q4 23 | $-0.11 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.4M | $195.2M |
| Total DebtLower is stronger | — | $55.0M |
| Stockholders' EquityBook value | $109.5M | $-239.5M |
| Total Assets | $430.9M | $327.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $34.4M | $195.2M | ||
| Q2 25 | $46.4M | — | ||
| Q1 25 | $35.9M | — | ||
| Q4 24 | $35.6M | $191.5M | ||
| Q3 24 | $23.0M | — | ||
| Q2 24 | $21.2M | — | ||
| Q1 24 | $21.2M | — | ||
| Q4 23 | $28.3M | — |
| Q3 25 | — | $55.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | $109.5M | $-239.5M | ||
| Q2 25 | $106.2M | — | ||
| Q1 25 | $102.4M | — | ||
| Q4 24 | $99.6M | $-251.7M | ||
| Q3 24 | $105.8M | $-242.9M | ||
| Q2 24 | $100.7M | — | ||
| Q1 24 | $102.8M | — | ||
| Q4 23 | $107.3M | — |
| Q3 25 | $430.9M | $327.5M | ||
| Q2 25 | $429.3M | — | ||
| Q1 25 | $388.4M | — | ||
| Q4 24 | $393.4M | $302.1M | ||
| Q3 24 | $387.0M | — | ||
| Q2 24 | $386.0M | — | ||
| Q1 24 | $365.8M | — | ||
| Q4 23 | $381.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $13.8M |
| Free Cash FlowOCF − Capex | $6.6M | $6.5M |
| FCF MarginFCF / Revenue | 12.3% | 7.7% |
| Capex IntensityCapex / Revenue | 0.1% | 8.8% |
| Cash ConversionOCF / Net Profit | 11.51× | 2.42× |
| TTM Free Cash FlowTrailing 4 quarters | $19.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $6.6M | $13.8M | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $-722.0K | — | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $90.0K | — | ||
| Q2 24 | $416.0K | — | ||
| Q1 24 | $-5.3M | — | ||
| Q4 23 | $6.2M | — |
| Q3 25 | $6.6M | $6.5M | ||
| Q2 25 | $9.1M | — | ||
| Q1 25 | $-986.0K | — | ||
| Q4 24 | $4.6M | — | ||
| Q3 24 | $58.0K | — | ||
| Q2 24 | $361.0K | — | ||
| Q1 24 | $-5.4M | — | ||
| Q4 23 | $6.2M | — |
| Q3 25 | 12.3% | 7.7% | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | -2.0% | — | ||
| Q4 24 | 9.3% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | -11.4% | — | ||
| Q4 23 | 13.2% | — |
| Q3 25 | 0.1% | 8.8% | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — | ||
| Q4 23 | 0.0% | — |
| Q3 25 | 11.51× | 2.42× | ||
| Q2 25 | 2.80× | — | ||
| Q1 25 | -0.90× | — | ||
| Q4 24 | 11.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAME
| Bankers Fidelity | $30.0M | 56% |
| American Southern | $23.7M | 44% |
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
